Pacira | Salg Og Administrasjonskostnader

Selling And Administration Expenses Endring Dato
Assertio Holdings USD 20.8M 4.03M 2023-09
Astellas Pharma JPY 179.28B 11.1B 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Cara Therapeutics USD 6.72M 790K 2023-09
Heron Therapeutics USD 24.6M 11.84M 2023-09
Ironwood Pharmaceuticals USD 38.67M 2.62M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Omeros USD 16.42M 5.16M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Perrigo USD 304M 28.3M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Revance Therapeutics USD 67.73M 8.62M 2023-09
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Xeris Pharmaceuticals USD 37.29M 348K 2023-09
Xoma USD 6.37M 591K 2023-09
Zoetis USD 565M 40M 2023-12



Pacira Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.